Zhang Shuyang

Deputy Director of the State Key Laboratory of Rare and Complex Diseases; National Health Commission Outstanding Young and Middle-aged Expert, State Council Special Government Allowance Expert, and Changjiang Scholar Dr. appointed by the Ministry of Education. Currently serves as Chairman of the Rare Diseases Branch of the Chinese Medical Association, Chairman of the Rare Disease Diagnosis and Treatment and Guarantee Committee of the National Health Commission, Director of the National Rare Disease Quality Control Center; Standing Committee Member and Secretary-General of the Cardiovascular Diseases Branch of the Chinese Medical Association; Vice Chairman of the Internal Medicine Branch of the Chinese Medical Doctor Association and President-elect of the Cardiovascular Diseases Branch; Vice President of the Chinese Research Hospital Association, etc.

Research areas include the common and individual mechanisms of genetic and rare diseases with Chinese characteristics, as well as precision diagnosis and treatment technologies. This includes mapping the distribution of rare diseases in China, establishing and developing rare disease databases, researching new diagnostic technologies for rare diseases, and developing new paradigms for rare disease drugs and treatment technologies. He has established a system for the diagnosis and treatment of complex cardiovascular diseases and a national direct reporting system for clinical diagnosis and treatment of rare diseases in my country. As project leader, he spearheaded the 13th and 14th Five-Year Plans for National Key Research and Development of Rare Diseases, establishing the first national rare disease registration platform, cohort database, and biobank. He led the construction and operation of a national multidisciplinary consultation platform and collaborative diagnosis and treatment network for rare diseases, promoting the construction of a rare disease quality control system. He innovated 33 rare disease diagnosis and treatment methods; edited the first national rare disease diagnosis and treatment guidelines and textbooks; and trained over 100,000 clinicians. He is the chief editor of "Rare Diseases," "Rare Disease Diagnosis and Treatment Guidelines (2019 Edition)," "Interpretation of the First Batch of Rare Disease Catalogues in China," and "Collection of Cases of Multidisciplinary Collaborative Diagnosis and Treatment of Rare Diseases," among others. He has received the National May 1st Labor Medal and the National March 8th Red Banner Pacesetter Award.